Viewing Study NCT00429559


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-02-02 @ 2:12 PM
Study NCT ID: NCT00429559
Status: COMPLETED
Last Update Posted: 2011-07-22
First Post: 2007-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma
Sponsor: Hellenic Oncology Research Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer; View
None Ovarian cancer; View
None Recurrent ovarian cancer platinum-resistant View